Analysis of Rectal Bleeding Risk with Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer

被引：0
|
作者：
McHaffie, Derek [1 ]
Adkison, Jarred [1 ]
Patel, Rakesh [1 ]
Khuntia, Deepak [1 ]
Ritter, Mark [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Health, Dept Human Oncol, Madison, WI 53706 USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2009年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：108 / 109
页数：2
相关论文
共 50 条
  • [31] Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: evidence from meta-analysis (vol 35, pg 9911, 2014)
    Sun, Libin
    Zhao, Yang
    Zhu, Shimiao
    Zhang, Hui
    Shang, Zhiqun
    Jiang, Ning
    Li, Gang
    Niu, Yuanjie
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9437 - 9437
  • [32] Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy
    Pepin, Abigail
    Shah, Sarthak
    Pernia, Monica
    Lei, Siyuan
    Ayoob, Marilyn
    Danner, Malika
    Yung, Thomas
    Collins, Brian T.
    Suy, Simeng
    Aghdam, Nima
    Collins, Sean P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Hypofractionated stereotactic body radiation therapy in low-risk prostate cancer
    Kim, H. J.
    Kim, W. C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S90 - S91
  • [34] Differences between 3d and vmat in hypofractionated radiation therapy for localized prostate cancer
    Navarro, I.
    Correa, R.
    Roman, A.
    Otero, A.
    Fernandez, A.
    Prieto, P.
    Garcia, M. J.
    Garcia, I.
    Ordonez, R.
    Jerez, I.
    Medina, J. A.
    Gomez, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S854 - S854
  • [35] Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy
    Dawson, Nancy A.
    Collins, Sean P.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 953 - 962
  • [36] RECTAL SPARING VIA HYDROGEL SPACER FOR DOSE-ESCALATED HYPOFRACTIONATED RADIATION COURSE IN HIGH RISK LOCALIZED PROSTATE CANCER: ANALYSIS OF DOSIMETRIC AND TOXICITY OUTCOMES
    Arcangeli, Stefano
    Gambardella, Pasquale
    [J]. ANTICANCER RESEARCH, 2014, 34 (05) : 2611 - 2612
  • [37] Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer
    Dash, Chiranjeev
    Demas, Kristina
    Uhm, Sunghae
    Hanscom, Heather N.
    Kim, Joy S.
    Suy, Simeng
    Davis, Kimberly M.
    Sween, Jennifer
    Collins, Sean
    Adams-Campbell, Lucile L.
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [38] Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    Cote, K
    Loffredo, M
    Renshaw, AA
    Schultz, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4567 - 4573
  • [39] Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    [J]. PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE, 2003, : 380 - 389
  • [40] Late Rectal Bleeding Following Radiation Therapy for Prostate Cancer: The Importance of Concomitant Medications and Cardiovascular Risk Factors
    Brennan, V. S.
    Nicholson, J.
    Kelly, P. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E531 - E531
12345